Efforts to increase U.S. Army warfighter capability and repair efficiency in theater were strengthened with the recent ...

ALZ, the second Phase 3 study of simufilam in Alzheimer’s disease, expected late first-quarter/early second-quarter ...

ALZ, the second Phase 3 study of simufilam in Alzheimer's disease, expected late first-quarter/early second-quarter 2025License agreement brings potential in a new therapeutic ...

Getrude Chemutay from Kericho County is a frustrated teacher after watching students she taught in primary school get ...

The day was packed with cooking demonstrations from guest chefs—including Tom Colicchio—and over 60 tasting tents offering an ...

The Teachers Service Commission (TSC) registers, recruits, deploys, promotes and disciplines teachers in Kenya’s public ...

Celebrity chef Tom Colicchio brought a humble and personal touch serving as the headliner for Tallahassee State College's ...

The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its ...

The 8th Theater Sustainment Command hosted Soldiers from the 143rd Expeditionary Sustainment Command and Australian Defense ...

Shares of Cassava Sciences, Inc. (NASDAQ: SAVA) climbed 7% following the company’s announcement of securing an exclusive license to a method of treatment patent for its drug candidate, simufilam. The ...

Cassava enters into a license agreement with Yale University granting intellectual property rights, including rights to an ...